Cortical pathophysiology in cocaine sef-administering HIV-1 transgenic rats

可卡因自我给药 HIV-1 转基因大鼠的皮质病理生理学

• 批准号: 8410441
• 负责人: XIU-TI HU
• 金额: $ 19.13万
• 依托单位: RUSH UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-07-15 至 2014-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8410441
• 关键词: AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Acute; Adult; Age; Age-Months; Behavior; Biochemical; Brain; Brain Injuries; Brain region; Cells; Cessation of life; Chronic; Cocaine; Cocaine Abuse; Cognition; Comorbidity; Diltiazem; Disease; Elderly; Emotions; Exhibits; Frequencies; Functional disorder; Future; Genetic Transcription; Gliosis; Goals; HIV; HIV Infections; HIV-1; Harvest; Homeostasis; Human; Immunohistochemistry; In Vitro; Individual; Infection; Injury; Intervention; Investigation; Knowledge; Lead; Literature; Medial; Mediating; Membrane; Methods; Microglia; Modeling; Molecular; Molecular Target; N-Methyl-D-Aspartate Receptors; Nature; Neurocognitive; Neurons; Neuropathogenesis; Outcome; Outcomes Research; Pathogenesis; Pathology; Prefrontal Cortex; Prosencephalon; Proteins; Protocols documentation; Pyramidal Cells; Rattus; Reporting; Research; Rewards; Role; Saline; Self Administration; Self-Administered; Severities; Site; Slice; Societies; Staging; Stimulus; Techniques; Testing; Therapeutic; Time; Toxic effect; Toxin; Training; Trans-Activators; Transgenic Organisms; Up-Regulation; Viral Proteins; Western Blotting; addiction; antiretroviral therapy; channel blockers; drug abstinence; dual diagnosis; experience; hippocampal pyramidal neuron; innovation; macrophage; molecular site; neuronal excitability; neuropathology; neuropsychiatry; novel; novel therapeutics; patch clamp; preclinical study; programs; research study; response; therapeutic target; young adult

DESCRIPTION (provided by applicant): Cocaine-abusing, HIV+ individuals experience more severe and rapidly evolving neuropsychiatric disorders and HIV-associated neurocognitive disorders (HAND) than non-abusing HIV+ individuals. These disorders reflect in part, a dysregulation of the medial prefrontal cortex (mPFC), but the underlying mechanisms are unclear. To significantly advance understanding of this phenomenon, we submit this R21 application to implement a new rat model of the comorbid human condition wherein critical features of both HIV+ and cocaine abuse are emulated to investigate the functional state of mPFC neurons. The research objectives are: (1) To reveal dysfunction of the mPFC in non-infectious, young (10-12 week old) adult HIV-1 transgenic (Tg) rats that chronically express multiple HIV-1 protein toxins in the brain, but do not exhibit the overt pathologies seen in old Tg rats (i.e., 10-12 months of age). (2 To determine if an exaggerated pathophysiology exists in the mPFC of HIV-1 Tg rats trained to self-administer cocaine. Our central hypothesis is that mPFC pyramidal neurons are more prone to over-activation in cocaine self-administering Tg rats than in saline-treated Tg rats or cocaine self-administering non-Tg rats. We will test this hypothesis with two Specific Aims. Aim 1 will validate [the level of microgliosis] in the mPFC, and determine their association with abnormally- enhanced neuronal excitability mediated via over-activated L-type Ca2+ channels in the young adult Tg rats. Non-Tg rats will serve as controls. Functional activity of mPFC pyramidal neurons will be assessed in ex vivo brain slices using patch-clamp recording techniques. We expect that the Tg rats will show [mPFC microgliosis] and hyper-excitability of pyramidal neurons mediated by over-activated L-channels, reflected by abnormally-increased responses to excitatory stimuli. Aim 2 will determine that cocaine self- administration enhances the pyramidal cell pathophysiology seen in the Tg rats. We expect that cocaine will exacerbate the hyper-excitability of mPFC pyramidal neurons observed in the Tg rats. This research is significant and innovative because it will provide the first means to ascertain the functional consequences of the chronic brain exposure of HIV-1 proteins under conditions of cocaine self-administration; in so doing, it will provide a completely novel method to investigate the molecular and cellular mechanisms responsible for this comorbid condition. The outcomes expected by the end of two years will determine that the HIV-1 proteins-induced pathology and cocaine abuse converge to dysregulate mPFC neuronal function via over- activated L-channels. These outcomes will guide our future investigations on mechanisms underlying the dysregulated Ca2+ homeostasis in the mPFC. Thus, this bold research will vertically elevate our understanding of the mechanisms that may contribute to the neuropathogenesis of HAND and neuropsychiatric disorders associated with HIV+ and cocaine abuse. This new knowledge will also lead to a R01 application in which novel therapeutic strategies will be developed to reduce such pathology. PUBLIC HEALTH RELEVANCE: The combination of cocaine abuse and AIDS accelerates the brain damage that can accompany either condition alone. Unfortunately, the frequency of this combination, or comorbidity, it is increasing in our society. This project will determine how toxic viral proteins produced by HIV in the rat brain, with or without cocaine self- administration, alter the function of neurons in a bran region (the medial prefrontal cortex) which, in humans, is vulnerable to both HIV infection and cocaine abuse. We propose that the detrimental effects of HIV toxins will be potentiated by cocaine on specific proteins that are critical for normal neuronal firing. By identifying common molecular targets of cocaine and HIV toxins, outcomes from this project should prove to be critically important in developing therapeutic means to slow the devastation of HIV/AIDS comorbidity with cocaine abuse, as well as to promote drug abstinence in these individuals.

描述（由申请人提供）：